HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $245,112,634 | -20.7% | 2,118,702 | -29.5% | 0.29% | -16.7% |
Q2 2023 | $308,957,595 | -4.6% | 3,003,963 | +1.2% | 0.35% | -6.5% |
Q1 2023 | $323,827,548 | +1.3% | 2,967,084 | +5.7% | 0.37% | -3.1% |
Q4 2022 | $319,542,207 | +392.7% | 2,807,928 | +167.9% | 0.38% | +361.4% |
Q3 2022 | $64,857,000 | -71.6% | 1,047,936 | -63.4% | 0.08% | -69.5% |
Q2 2022 | $228,679,000 | -16.5% | 2,867,093 | +10.2% | 0.27% | -3.2% |
Q1 2022 | $273,734,000 | +38.7% | 2,601,790 | +42.1% | 0.28% | +39.1% |
Q4 2021 | $197,356,000 | +146.7% | 1,831,440 | +150.8% | 0.20% | +127.0% |
Q3 2021 | $79,997,000 | +26.1% | 730,299 | +7.8% | 0.09% | +30.9% |
Q2 2021 | $63,429,000 | +8.1% | 677,370 | +6.3% | 0.07% | +1.5% |
Q1 2021 | $58,657,000 | +35.4% | 637,303 | +7.6% | 0.07% | +26.4% |
Q4 2020 | $43,309,000 | -27.8% | 592,056 | -23.3% | 0.05% | -28.4% |
Q3 2020 | $59,958,000 | +54.2% | 771,861 | +10.4% | 0.07% | +42.3% |
Q2 2020 | $38,873,000 | +74.9% | 699,412 | -6.8% | 0.05% | +40.5% |
Q1 2020 | $22,221,000 | -13.5% | 750,213 | +5.8% | 0.04% | +2.8% |
Q4 2019 | $25,678,000 | +33.3% | 709,330 | +0.2% | 0.04% | +24.1% |
Q3 2019 | $19,269,000 | +13.5% | 707,630 | +0.3% | 0.03% | +11.5% |
Q2 2019 | $16,977,000 | – | 705,591 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |